Daren Tang 2026 First-Half Revenue Down 7.39%, Net Profit Down 66.55% on Year-Ago One-Off Gain
Daren Tang reported first-half 2026 revenue of RMB2.455 billion, down 7.39% year on year, and net profit attributable to shareholders of RMB645 million, down 66.55%. The sharp profit decline reflects the absence of a one-off gain from the sale of a 12% stake in Sino-American Tianjin Smith Kline in the year-ago period, which contributed RMB1.31 billion in after-tax profit. Basic earnings per share were RMB0.84.
Daren Tang disclosed its 2026 interim report. During the reporting period, the company achieved operating revenue of RMB2.455 billion, down 7.39% year on year; net profit attributable to shareholders of the listed company was RMB645 million, down 66.55%; basic earnings per share were RMB0.84.
The company stated that in the same period of 2025, it recognised after-tax net profit of RMB1.31 billion from the sale of a 12% equity stake in its associate Sino-American Tianjin Smith Kline. As there were no such non-recurring items in the current period, net profit declined significantly year on year.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is neutral for Traditional Chinese Medicine, with intensity 20/100 and 80% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.